View Older Stories View More Recent Stories

Nov 8, 2022 04:05PM Exagen Inc. to Participate in Fourth Quarter Investor Conferences
Nov 8, 2022 04:05PM Exagen Inc. to Participate in Fourth Quarter Investor Conferences
Oct 31, 2022 04:05PM Exagen to Announce Third Quarter 2022 Financial Results on November 14, 2022
Oct 31, 2022 04:05PM Exagen to Announce Third Quarter 2022 Financial Results on November 14, 2022
Oct 17, 2022 09:00AM Exagen (XGN) Appoints John Aballi as CEO
Oct 17, 2022 09:00AM Exagen Announces Appointment of John Aballi as CEO
Oct 17, 2022 09:00AM Exagen Announces Appointment of John Aballi as CEO
Oct 4, 2022 08:26AM Exagen Inc (XGN) Appoints Andrew L. Concoff as Chief Innovation Officer
Oct 4, 2022 08:25AM Exagen Announces Appointment of Andrew L. Concoff MD, FACR, CAQSM, as Chief Innovation Officer
Oct 4, 2022 08:25AM Exagen Announces Appointment of Andrew L. Concoff MD, FACR, CAQSM, as Chief Innovation Officer
Sep 20, 2022 04:05PM Exagen Announces Acceptance of Multiple Abstracts at ACR 2022 Annual Meeting
Sep 20, 2022 04:05PM Exagen Announces Acceptance of Multiple Abstracts at ACR 2022 Annual Meeting
Sep 1, 2022 04:05PM Exagen Inc. Collaboration Leads to Characterization of Broad Autoreactivity in Severe COVID-19 Patients
Sep 1, 2022 04:05PM Exagen Inc. Collaboration Leads to Characterization of Broad Autoreactivity in Severe COVID-19 Patients
Aug 4, 2022 04:06PM Exagen Initiates Study to Predict Rheumatoid Arthritis Drug Response (RADR) in Patients with RA
Aug 4, 2022 04:06PM Exagen Initiates Study to Predict Rheumatoid Arthritis Drug Response (RADR) in Patients with RA
Aug 4, 2022 04:05PM Exagen Inc. Reports Second Quarter 2022 Results
Aug 4, 2022 04:05PM Exagen Inc. Reports Second Quarter 2022 Results
Jul 25, 2022 04:05PM Exagen Inc. to Participate in the Canaccord Genuity 42nd Annual Growth Conference
Jul 25, 2022 04:05PM Exagen Inc. to Participate in the Canaccord Genuity 42nd Annual Growth Conference
Jul 21, 2022 04:05PM Exagen to Announce Second Quarter 2022 Financial Results on August 4, 2022
Jul 21, 2022 04:05PM Exagen to Announce Second Quarter 2022 Financial Results on August 4, 2022
Jul 5, 2022 08:25AM Exagen Inc (XGN) Releases Largest Comparative Utility Study in Lupus Diagnostics Confirming AVISE® Lupus Delivers Unparalleled Utility
Jul 5, 2022 08:25AM Exagen Releases Largest Comparative Utility Study in Lupus Diagnostics Confirming AVISE® Lupus Delivers Unparalleled Utility
Jul 5, 2022 08:25AM Exagen Releases Largest Comparative Utility Study in Lupus Diagnostics Confirming AVISE® Lupus Delivers Unparalleled Utility
Jun 9, 2022 08:26AM Exagen Inc (XGN) Expands Coverage with MediNcrease
Jun 9, 2022 08:25AM Exagen Inc. Expands Coverage with MediNcrease
Jun 9, 2022 08:25AM Exagen Inc. Expands Coverage with MediNcrease
May 26, 2022 04:05PM Exagen Inc. to Participate in the William Blair 42nd Annual Growth Stock Conference
May 26, 2022 04:05PM Exagen Inc. to Participate in the William Blair 42nd Annual Growth Stock Conference
May 16, 2022 04:07PM Exagen Inc (XGN) Expands Coverage with Alivio Health
May 16, 2022 04:05PM Exagen Inc. Expands Coverage with Alivio Health, Partnering to Provide More Accurate Diagnostic Testing with AVISE® CTD and AVISE® Lupus
May 16, 2022 04:05PM Exagen Inc. Expands Coverage with Alivio Health, Partnering to Provide More Accurate Diagnostic Testing with AVISE® CTD and AVISE® Lupus
May 11, 2022 04:07PM Exagen Inc (XGN) Announces New PLA Code and Medicare Pricing for Proprietary AVISE Lupus Test
May 11, 2022 04:06PM Exagen Inc. Announces New PLA Code and Medicare Pricing for Proprietary AVISE® Lupus Test
May 11, 2022 04:06PM Exagen Inc. Announces New PLA Code and Medicare Pricing for Proprietary AVISE® Lupus Test
May 11, 2022 04:05PM Exagen Inc. Reports First Quarter 2022 Results
May 11, 2022 04:05PM Exagen Inc. Reports First Quarter 2022 Results
May 1, 2022 12:00PM Exagen Announces Five-Week Campaign for Lupus Awareness Month
May 1, 2022 12:00PM Exagen Announces Five-Week Campaign for Lupus Awareness Month
Apr 25, 2022 04:05PM Exagen to Announce First Quarter 2022 Financial Results on May 11, 2022
Apr 25, 2022 04:05PM Exagen to Announce First Quarter 2022 Financial Results on May 11, 2022
May 3, 2021 08:25AM Exagen Announces New Campaign and Initiatives for Lupus Awareness Month
May 3, 2021 08:25AM Exagen Announces New Campaign and Initiatives for Lupus Awareness Month
View More Recent Stories View Older Stories